CONTEXT: A polymorphism in the FSHB promoter (-211G→T, rs10835638) was found to be associated with decreased FSH, elevated LH, reduced testosterone, and oligozoospermia in males. Although FSH is pivotal for ovarian function, no data on consequences of FSHB -211G→T are available in females. OBJECTIVE: We studied the effects of FSHB -211G→T on the hypothalamic-pituitary-ovarian axis in women. DESIGN AND SETTING: In a university-based in vitro fertilization unit, women undergoing standardized diagnostics were genotyped and compared with a fertile control group. PATIENTS: The study group consisted of 365 thoroughly characterized women with normal menstrual cycle intervals and proven ovulation, with predominantly male-factor infertility. The independently recruited control group included 438 women with proven fertility and no history of abortions. MAIN OUTCOME MEASURES: Distribution of alleles and genotypes were compared between the study group and controls. In the study group, associations of endocrine parameters with FSHB -211G→T were assessed. RESULTS: Allele and genotype frequencies were not significantly different between the study population and controls (T-allele: 14.4 vs. 16.6%; TT-homozygotes: 2.5 vs. 3.2%). The FSHB -211G→T TT-genotype was strongly associated with elevated FSH (TT-homozygosity effect 2.05 U/liter, P = 0.003). LH increased with the number of T-alleles (1.30 U/liter per T-allele, P < 0.001). Additionally, FSHB -211G→T was associated with reduced progesterone (-1.96 ng/ml per T-allele, P = 0.047). CONCLUSIONS: This is a report on phenotypic consequences of FSHB -211G→T on the hypothalamic-pituitary-ovarian axis in women. The findings, partially contradictory to those in men, point to a gender-specific compensatory mechanism of gonadotropin secretion, probably involving progesterone.
CONTEXT: A polymorphism in the FSHB promoter (-211G→T, rs10835638) was found to be associated with decreased FSH, elevated LH, reduced testosterone, and oligozoospermia in males. Although FSH is pivotal for ovarian function, no data on consequences of FSHB -211G→T are available in females. OBJECTIVE: We studied the effects of FSHB -211G→T on the hypothalamic-pituitary-ovarian axis in women. DESIGN AND SETTING: In a university-based in vitro fertilization unit, women undergoing standardized diagnostics were genotyped and compared with a fertile control group. PATIENTS: The study group consisted of 365 thoroughly characterized women with normal menstrual cycle intervals and proven ovulation, with predominantly male-factor infertility. The independently recruited control group included 438 women with proven fertility and no history of abortions. MAIN OUTCOME MEASURES: Distribution of alleles and genotypes were compared between the study group and controls. In the study group, associations of endocrine parameters with FSHB -211G→T were assessed. RESULTS: Allele and genotype frequencies were not significantly different between the study population and controls (T-allele: 14.4 vs. 16.6%; TT-homozygotes: 2.5 vs. 3.2%). The FSHB -211G→T TT-genotype was strongly associated with elevated FSH (TT-homozygosity effect 2.05 U/liter, P = 0.003). LH increased with the number of T-alleles (1.30 U/liter per T-allele, P < 0.001). Additionally, FSHB -211G→T was associated with reduced progesterone (-1.96 ng/ml per T-allele, P = 0.047). CONCLUSIONS: This is a report on phenotypic consequences of FSHB -211G→T on the hypothalamic-pituitary-ovarian axis in women. The findings, partially contradictory to those in men, point to a gender-specific compensatory mechanism of gonadotropin secretion, probably involving progesterone.
Authors: Katherine S Ruth; Ana Luiza G Soares; Maria-Carolina Borges; A Heather Eliassen; Susan E Hankinson; Michael E Jones; Peter Kraft; Hazel B Nichols; Dale P Sandler; Minouk J Schoemaker; Jack A Taylor; Anne Zeleniuch-Jacquotte; Deborah A Lawlor; Anthony J Swerdlow; Anna Murray Journal: Hum Mol Genet Date: 2019-04-15 Impact factor: 6.150
Authors: A Tanase; D Nemescu; R Popescu; B F Toma; R D Matasariu; M Onofriescu Journal: Acta Endocrinol (Buchar) Date: 2020 Apr-Jun Impact factor: 0.877
Authors: Shao-Hua Xie; Rui Fang; Mingtao Huang; Juncheng Dai; Aaron P Thrift; Lesley A Anderson; Wong-Ho Chow; Leslie Bernstein; Marilie D Gammon; Harvey A Risch; Nicholas J Shaheen; Brian J Reid; Anna H Wu; Prasad G Iyer; Geoffrey Liu; Douglas A Corley; David C Whiteman; Carlos Caldas; Paul D Pharoah; Laura J Hardie; Rebecca C Fitzgerald; Hongbing Shen; Thomas L Vaughan; Jesper Lagergren Journal: Clin Gastroenterol Hepatol Date: 2019-11-19 Impact factor: 11.382
Authors: Wei Zhao; Jennifer A Smith; Lawrence F Bielak; Edward A Ruiz-Narvaez; Miao Yu; Michelle M Hood; Patricia A Peyser; Sharon L R Kardia; Sioban D Harlow Journal: Menopause Date: 2021-04-19 Impact factor: 2.953
Authors: E Bosch; C Alviggi; M Lispi; A Conforti; A C Hanyaloglu; D Chuderland; M Simoni; N Raine-Fenning; P Crépieux; S Kol; V Rochira; T D'Hooghe; P Humaidan Journal: Hum Reprod Date: 2021-05-17 Impact factor: 6.918
Authors: Wei Zhao; Jennifer A Smith; Miao Yu; Carolyn J Crandall; Rebecca C Thurston; Michelle M Hood; Edward Ruiz-Narvaez; Patricia A Peyser; Sharon L R Kardia; Sioban D Harlow Journal: Menopause Date: 2021-04-26 Impact factor: 3.310
Authors: Lawrence F Bielak; Patricia A Peyser; Jennifer A Smith; Wei Zhao; Edward A Ruiz-Narvaez; Sharon L R Kardia; Sioban D Harlow Journal: Mol Genet Genomic Med Date: 2022-02-18 Impact factor: 2.473
Authors: Katherine S Ruth; Purdey J Campbell; Shelby Chew; Ee Mun Lim; Narelle Hadlow; Bronwyn G A Stuckey; Suzanne J Brown; Bjarke Feenstra; John Joseph; Gabriela L Surdulescu; Hou Feng Zheng; J Brent Richards; Anna Murray; Tim D Spector; Scott G Wilson; John R B Perry Journal: Eur J Hum Genet Date: 2015-05-27 Impact factor: 4.246